Laurus Labs Ltd News

Laurus Labs zooms 128% from March low; hits new high in weak market

Laurus Labs Q2 outlook: On the EBITDA front, analysts at Kotak Institutional Equities build in 67% YoY growth to ₹680 crore in Q2FY27 with EBITDA margin expansion of 680 bps to 31.2%.

CDMO players to maintain outperformance on multiple growth triggers

Divi's Laboratories remains the top pick for most brokerages in this segment, even as valuations turn rich after the sharp rally

On a healthy note! FPIs return to healthcare, pour ₹15,800 cr since July

In the first half of September, healthcare saw FPI inflows of ₹2,114 crore, the highest among all sectors, adding to the ₹5,931 crore and ₹7,755 crore buying seen in August and July, respectively.

Pharma stocks zoom: Laurus Labs, Aurobindo hit new highs in trade

The BSE Healthcare index rallied over 1% in Monday's trade. Thus far in the financial year 2026-27, it outperformed the market by soaring 25%, against a near 4% rise in the BSE Sensex.

₹1 trillion market-cap stock club swells 27% to 119 in FY27

Among the new additions, Laurus Labs saw its market-cap rise 92 per cent to ₹1.03 trillion from ₹53,546 crore as of March 30, 2026

MSCI rejig: Laurus, Lenskart among 4 stocks set for $1.5 bn inflows

The MSCI Standard Index will see four additions, Adani Energy Solutions, Billionbrains Garage Ventures, Laurus Labs, and Lenskart Solutions.

Pharma shares shine: Divi's, Laurus hit new highs; zoom up to 91% in FY27

India's CRDMO sector growth rebounded to 19% YoY in Q1FY27 versus just 9% YoY in the March 2026 quarter, marking the highest growth level since the December 2024 quarter, notes Jefferies.

Laurus joins ₹1 trillion market cap club as stock zooms 120% in 1 year

In the past month, Laurus Labs outperformed the market by surging 22 per cent, as compared to 2.1 per cent rise in the Nifty Midcap 50 index.

Stocks to buy: Hero MotoCorp among 3 stock ideas by MOFSL

Motilal Oswal's Chandan Taparia recommends Hero MotoCorp, Siemens, and Laurus Labs as technical buy ideas, citing bullish chart patterns, breakout formations, and strong sectoral momentum.

Healthcare up for 4th straight month; Divis, Laurus, Torrent at new highs

The BSE Healthcare hit a new high of 51,108 on Friday, rallying 3.7% in July. The index has surged 22% since April 2026.

Sun Pharma, TVS Motor, Nestle, Divis among 11 BSE 500 stocks at new highs

Among others, Manappuram Finance, Marico, Radico Khaitan, Redington, Welspun Corp, Laurus Labs and Sai Life Sciences also touched respective all-time highs in trade on Thursday.

Laurus Labs extends rally, up 97% from Feb low; tops Dr Reddy's market-cap

Laurus Labs quoted higher for the fourth straight day, surging 15% in this period after delivering record quarterly revenue with expanded profitability and continued portfolio transformation.

Madhusudan Kela, Vijay Kedia: Smart investor portfolios beat markets in July

G Chokkalingam, founder and head of research at Equinomics Research expects markets to reward stocks of companies where there is valuation comfort, earnings visibility rather than a broad-based rally.

Laurus Labs rallies 4%, up 55% in 5 months; brokerages see more upside

The stock price of Laurus Labs hit a new high of ₹1,662.45 in intra-day deals on Monday; the stock has zoomed 176% in the past 14 months from levels of ₹601.75 on May 27, 2025.

Laurus Labs stock jumps 2%, hits new high on 125% surge in Q1 profit

Laurus Labs on Friday reported a 124.7% YoY surge in Q1 consolidated net profit at ₹361.99 crore, backed by 28.8% growth in total income. The stock has nearly doubled in the last one year.

Pharma index surges 2%; Torrent, Mankind, Cipla, Aurobindo soar up to 5%

Pharma stocks: RPG Life, Thyrocare, Hester Biosciences, Rubicon Research, IOL Chemicals, Emcure and Suven Life from the BSE Healthcare index rallied between 4% and 8% on Monday.

Nifty Midcap 50, Nifty Smallcap 50 indices hit lifetime highs

The Nifty Midcap 50 and Smallcap 50 have gained 21 per cent and 29 per cent thus far in FY27 led by strong gains in BHEL, Laurus Labs, Prestige Estates, Aegis Logistics and Welspun Corp.

Nifty Pharma rallies 2%; Laurus, Ipca, Aurobindo, Torrent hit record highs

In the past month, the Nifty Pharma index outperformed the market by surging 7.4 per cent, as compared to 4.2 per cent rise in the Nifty 50.

Laurus Labs zooms 53% in Q1FY27; logs sharpest quarterly rally in 5 years

Sustained clinical and commercial contracting across technologies and sites driving good growth outlook for CDMO business, the company said.

Nifty Pharma index up 2%; Dr Reddy's, Ajanta, Ipca, Cipla surge up to 5%

In the past seven trading days, the Nifty Pharma index outperformed the market by soaring 5.4 per cent, as compared to 0.1 per cent decline in the Nifty 50.